BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Loginov VI, Pronina IV, Burdennyy AM, Filippova EA, Kazubskaya TP, Kushlinsky DN, Utkin DO, Khodyrev DS, Kushlinskii NE, Dmitriev AA, Braga EA. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis. Gene 2018;662:28-36. [DOI: 10.1016/j.gene.2018.04.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Singh A, Gupta S, Sachan M. Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives. Front Cell Dev Biol 2019;7:182. [PMID: 31608277 DOI: 10.3389/fcell.2019.00182] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
2 Filippova EA, Loginov VI, Pronina IV, Khodyrev DS, Burdennyy AM, Kazubskaya TP, Braga EA. A Group of Hypermethylated miRNA Genes in Breast Cancer and Their Diagnostic Potential. Mol Biol 2019;53:371-8. [DOI: 10.1134/s0026893319030051] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Braga EA, Fridman MV, Loginov VI, Dmitriev AA, Morozov SG. Molecular Mechanisms in Clear Cell Renal Cell Carcinoma: Role of miRNAs and Hypermethylated miRNA Genes in Crucial Oncogenic Pathways and Processes. Front Genet 2019;10:320. [PMID: 31110513 DOI: 10.3389/fgene.2019.00320] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 10.7] [Reference Citation Analysis]
4 Wang J, Li C, Xu L, Yang C, Zhang X. MiR-1193 was sponged by LINC00963 and inhibited cutaneous squamous cell carcinoma progression by targeting SOX4. Pathol Res Pract 2019;215:152600. [PMID: 31477326 DOI: 10.1016/j.prp.2019.152600] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
5 Shu J, Xiao L, Yan S, Fan B, Zou X, Yang J. Mechanism of MicroRNA-375 Promoter Methylation in Promoting Ovarian Cancer Cell Malignancy. Technol Cancer Res Treat 2021;20:1533033820980115. [PMID: 33928819 DOI: 10.1177/1533033820980115] [Reference Citation Analysis]
6 Song H, Shi L, Xu Y, Xu T, Fan R, Cao M, Xu W, Song J. BRD4 promotes the stemness of gastric cancer cells via attenuating miR-216a-3p-mediated inhibition of Wnt/β-catenin signaling. Eur J Pharmacol 2019;852:189-97. [PMID: 30876979 DOI: 10.1016/j.ejphar.2019.03.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
7 Pronina IV, Uroshlev LA, Moskovtsev AA, Zaichenko DM, Filippova EA, Fridman MV, Burdennyy AM, Loginov VI, Kazubskaya TP, Kushlinskii NE, Dmitriev AA, Braga EA, Brovkina OI. Dysregulation of lncRNA–miRNA–mRNA Interactome as a Marker of Metastatic Process in Ovarian Cancer. Biomedicines 2022;10:824. [DOI: 10.3390/biomedicines10040824] [Reference Citation Analysis]
8 Pajares MJ, Alemany-Cosme E, Goñi S, Bandres E, Palanca-Ballester C, Sandoval J. Epigenetic Regulation of microRNAs in Cancer: Shortening the Distance from Bench to Bedside. Int J Mol Sci 2021;22:7350. [PMID: 34298969 DOI: 10.3390/ijms22147350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Cacabelos R. Pathoepigenetics: The Role of Epigenetic Biomarkers in Disease Pathogenesis. Pharmacoepigenetics. Elsevier; 2019. pp. 139-89. [DOI: 10.1016/b978-0-12-813939-4.00005-x] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Kushlinskii NE, Loginov VI, Utkin DO, Filippova EA, Burdennyy AM, Korotkova EA, Pronina IV, Lukina SS, Smirnova AV, Gershtein ES, Braga EA. Novel miRNAs as Potential Regulators of PD-1/PD-L1 Immune Checkpoint, and Prognostic Value of MIR9-1 and MIR124-2 Methylation in Ovarian Cancer. Mol Biol 2020;54:870-5. [DOI: 10.1134/s0026893320060072] [Reference Citation Analysis]
11 Kushlinskii NE, Utkin DO, Loginov VI, Filippova EA, Burdennyy AM, Kushlinsky DN, Pronina IV, Braga EA. [Clinical significance of methylation of a group of miRNA genes in patients with ovarian cancer.]. Klin Lab Diagn 2020;65:321-7. [PMID: 32298550 DOI: 10.18821/0869-2084-2020-65-5-321-327] [Reference Citation Analysis]
12 Liu CH, Jing XN, Liu XL, Qin SY, Liu MW, Hou CH. Tumor-suppressor miRNA-27b-5p regulates the growth and metastatic behaviors of ovarian carcinoma cells by targeting CXCL1. J Ovarian Res 2020;13:92. [PMID: 32782028 DOI: 10.1186/s13048-020-00697-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
13 Brovkina OI, Pronina IV, Burdennyy AM, Uroshlev LA, Filippova EA, Fridman MV, Kazubskaya TP, Zhordania KI, Loginov VI, Kushlinskii NE, Braga EA. The Role of Long Non-Coding RNA CCAT1 and SNHG14 in Activation of Some Protein-Coding Genes Associated with the Development of Ovarian Cancer. Bull Exp Biol Med 2022. [PMID: 35501644 DOI: 10.1007/s10517-022-05473-8] [Reference Citation Analysis]
14 Kumar V, Gupta S, Chaurasia A, Sachan M. Evaluation of Diagnostic Potential of Epigenetically Deregulated MiRNAs in Epithelial Ovarian Cancer. Front Oncol 2021;11:681872. [PMID: 34692473 DOI: 10.3389/fonc.2021.681872] [Reference Citation Analysis]
15 Zhang Y, Zhang W, Wang H, Yang B. miR-21 Contributes to Human Amniotic Membrane-Derived Mesenchymal Stem Cell Growth and Human Amniotic Membrane-Derived Mesenchymal Stem Cell-Induced Immunoregulation. Genetic Testing and Molecular Biomarkers 2018;22:665-73. [DOI: 10.1089/gtmb.2018.0116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
16 Brovkina OI, Pronina IV, Uroshlev LA, Fridman MV, Loginov VI, Kazubskaya TP, Utkin DO, Kushlinskii NE, Braga EA. Identification of Novel Differentially Expressing Long Non-Coding RNAs with Oncogenic Potential. Mol Biol 2021;55:548-54. [DOI: 10.1134/s0026893321020175] [Reference Citation Analysis]
17 Wang J, Wang N, Li Z, Yang L, Jing Y, Cheng J, Li J. Identification of key genes and construction of microRNA-mRNA regulatory networks in non-small cell lung cancer. Cancer Genetics 2018;228-229:47-54. [DOI: 10.1016/j.cancergen.2018.08.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
18 Filippova EA, Loginov VI, Burdennyi AM, Braga EA, Pronina IV, Kazubskaya TP, Kushlinskii DN, Utkin DO, Fridman MV, Khodyrev DS, Kushlinskii NE. Hypermethylated Genes of MicroRNA in Ovarian Carcinoma: Metastasis Prediction Marker Systems. Bull Exp Biol Med 2019;167:79-83. [DOI: 10.1007/s10517-019-04465-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
19 Lukina SS, Burdennyy AM, Filippova EA, Pronina IV, Ivanova NA, Kazubskaya TP, Kushlinskii DN, Utkin DO, Loginov VI, Braga EA, Kushlinskii NE. Synergy between the Levels of Methylation of microRNA Gene Sets in Primary Tumors and Metastases of Ovarian Cancer Patients. Bull Exp Biol Med 2022. [PMID: 35622253 DOI: 10.1007/s10517-022-05499-y] [Reference Citation Analysis]
20 Bo H, Cao K, Tang R, Zhang H, Gong Z, Liu Z, Liu J, Li J, Fan L. A network-based approach to identify DNA methylation and its involved molecular pathways in testicular germ cell tumors. J Cancer 2019;10:893-902. [PMID: 30854095 DOI: 10.7150/jca.27491] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
21 Kumar V, Gupta S, Varma K, Sachan M. MicroRNA as Biomarker in Ovarian Cancer Management: Advantages and Challenges. DNA Cell Biol 2020. [PMID: 33156705 DOI: 10.1089/dna.2020.6024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Loginov VI, Pronina IV, Filippova EA, Burdennyy AM, Lukina SS, Kazubskaya TP, Uroshlev LA, Fridman MV, Brovkina OI, Apanovich NV, Karpukhin AV, Stilidi IS, Kushlinskii NE, Dmitriev AA, Braga EA. Aberrant Methylation of 20 miRNA Genes Specifically Involved in Various Steps of Ovarian Carcinoma Spread: From Primary Tumors to Peritoneal Macroscopic Metastases. Int J Mol Sci 2022;23:1300. [PMID: 35163224 DOI: 10.3390/ijms23031300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
23 Liu CL, Yuan RH, Mao TL. The Molecular Landscape Influencing Prognoses of Epithelial Ovarian Cancer. Biomolecules 2021;11:998. [PMID: 34356623 DOI: 10.3390/biom11070998] [Reference Citation Analysis]
24 Zeng D, He S, Zhao N, Hu M, Gao J, Yu Y, Huang J, Shen Y, Li H. Promoter Hypomethylation of miR-124 Gene Is Associated With Major Depressive Disorder. Front Mol Neurosci 2021;14:771103. [PMID: 34992522 DOI: 10.3389/fnmol.2021.771103] [Reference Citation Analysis]
25 Ortiz IMDP, Barros-Filho MC, Dos Reis MB, Beltrami CM, Marchi FA, Kuasne H, do Canto LM, de Mello JBH, Abildgaard C, Pinto CAL, Kowalski LP, Rogatto SR. Loss of DNA methylation is related to increased expression of miR-21 and miR-146b in papillary thyroid carcinoma. Clin Epigenetics 2018;10:144. [PMID: 30454026 DOI: 10.1186/s13148-018-0579-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
26 Burdennyy AM, Filippova EA, Ivanova NA, Lukina SS, Pronina IV, Loginov VI, Fridman MV, Kazubskaya TP, Utkin DO, Braga EA, Kushlinskii NE. Hypermethylation of Genes in New Long Noncoding RNA in Ovarian Tumors and Metastases: A Dual Effect. Bull Exp Biol Med 2021;171:370-4. [PMID: 34292442 DOI: 10.1007/s10517-021-05230-3] [Reference Citation Analysis]
27 Braga EA, Fridman MV, Moscovtsev AA, Filippova EA, Dmitriev AA, Kushlinskii NE. LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms. Int J Mol Sci 2020;21:E8855. [PMID: 33238475 DOI: 10.3390/ijms21228855] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
28 Filippova EA, Pronina IV, Lukina SS, Kazubskaya TP, Braga EA, Burdennyi AM, Loginov VI. Relationship of the Levels of microRNA Gene Methylation with the Level of Their Expression and Pathomorphological Characteristics of Breast Cancer. Bull Exp Biol Med 2021;171:764-9. [PMID: 34705180 DOI: 10.1007/s10517-021-05312-2] [Reference Citation Analysis]
29 Gong ZH, Zhou F, Shi C, Xiang T, Zhou CK, Wang QQ, Jiang YS, Gao SF. miRNA-221 promotes cutaneous squamous cell carcinoma progression by targeting PTEN. Cell Mol Biol Lett 2019;24:9. [PMID: 30891072 DOI: 10.1186/s11658-018-0131-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
30 Hussen BM, Hidayat HJ, Salihi A, Sabir DK, Taheri M, Ghafouri-Fard S. MicroRNA: A signature for cancer progression. Biomed Pharmacother 2021;138:111528. [PMID: 33770669 DOI: 10.1016/j.biopha.2021.111528] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
31 Seborova K, Vaclavikova R, Rob L, Soucek P, Vodicka P. Non-Coding RNAs as Biomarkers of Tumor Progression and Metastatic Spread in Epithelial Ovarian Cancer. Cancers (Basel) 2021;13:1839. [PMID: 33921525 DOI: 10.3390/cancers13081839] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Nguyen VHL, Yue C, Du KY, Salem M, O'Brien J, Peng C. The Role of microRNAs in Epithelial Ovarian Cancer Metastasis. Int J Mol Sci 2020;21:E7093. [PMID: 32993038 DOI: 10.3390/ijms21197093] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]